A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 ...

The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

A registered dietitian reveals nine food that work like weight-loss drugs, helping to curb cravings and suppress your ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies are looking to enter the space. Earlier this month, British pharma leader ...

Analysts chewed over early data showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone mineral ...

Based on a study sponsored by Zepbound's manufacturer, Eli Lilly, people without diabetes taking ... Zepbound and Wegovy may also make birth control pills less effective. Peptide medications for ...

The drug is a promising potential competitor in the weight loss drug market that is designed to be taken monthly rather than ...